Complete high-density lipoproteins in nanoparticle corona.

Summary, in English

In a biological environment, nanoparticles immediately become covered by an evolving corona of biomolecules, which gives a biological identity to the nanoparticle and determines its biological impact and fate. Previous efforts at describing the corona have concerned only its protein content. Here, for the first time, we show, using size exclusion chromatography, NMR, and pull-down experiments, that copolymer nanoparticles bind cholesterol, triglycerides and phospholipids from human plasma, and that the binding reaches saturation. The lipid and protein binding patterns correspond closely with the composition of high-density lipoprotein (HDL). By using fractionated lipoproteins, we show that HDL binds to copolymer nanoparticles with much higher specificity than other lipoproteins, probably mediated by apolipoprotein A-I. Together with the previously identified protein binding patterns in the corona, our results imply that copolymer nanoparticles bind complete HDL complexes, and may be recognized by living systems as HDL complexes, opening up these transport pathways to nanoparticles. Apolipoproteins have been identified as binding to many other nanoparticles, suggesting that lipid and lipoprotein binding is a general feature of nanoparticles under physiological conditions.

• Author: Erik Hellstrand; Iseult Lynch; Astra Andersson; Torbjörn Drakenberg; Björn Dahlbäck; Kenneth A Dawson; Sara Linse; Tommy Cedervall
• Department/s: Biophysical Chemistry; Clinical Chemistry, Malmö
• Publishing year: 2009
• Language: English
• Pages: 3372-3381
• Publication/Series: The FEBS Journal
• Volume: 276
• Issue: 12
• Links: http://dx.doi.org/10.1111/j.1742-4658.2009.07062.x
• Document type: Journal article
• Publisher: Wiley-Blackwell
• Topic: Medicinal Chemistry
• Status: Published
• Research group: Clinical Chemistry, Malmö
• ISBN/ISSN/Other: ISSN: 1742-464X